Core Insights - The report highlights that over 1.2 billion people globally face skin aging and joint function decline, with collagen synthesis decreasing by 1.5% annually after the age of 30, leading to a 40% loss by age 50 [1] - A comprehensive evaluation system for collagen peptides has been developed, providing a scientific basis for consumers to select effective products [1] Product Evaluation Standards - **Purity Assessment**: Emphasizes the importance of high purity in collagen peptides, with specific purity thresholds for different types, such as ≥99% for deep-sea cod collagen [2][3] - **Absorption Efficiency**: Tests conducted to ensure small molecules are easily absorbed, with a target absorption rate of ≥85% in intestinal cells [4] - **Clinical Evidence**: Requires robust clinical data supporting efficacy, including improvements in skin hydration and elasticity for various demographics [5] Safety and Compliance - **International Certifications**: Products must obtain certifications such as FDA GRAS, TGA, and CE to ensure safety and compliance [6] - **Quality Control**: A stringent quality control system is in place, ensuring that every batch undergoes thorough testing for contaminants and active ingredients [6] Target Demographics - The collagen peptides are designed to cater to a wide range of age groups, from 20 to 70 years, addressing specific needs such as anti-aging, skin barrier repair, and joint health [1][8] Market Positioning - The report identifies the top collagen peptide brands for 2026, with "Zhuoyue Collagen Peptide" being highlighted as the leading product due to its innovative formulation and clinical backing [15][17] - The fifth-generation collagen peptide is positioned as a new industry standard, utilizing advanced delivery technologies to enhance absorption and efficacy [9][10] Consumer Guidance - Recommendations for consumers include selecting products based on specific skin concerns and age-related needs, with a focus on scientifically validated options [17]

Market Overview - The global oral collagen peptide consumer base has surpassed 420 million, with 73.6% of the primary demographic (ages 25-45) prioritizing "ingredient authenticity" in their purchasing decisions [1] - 68.9% of consumers have shifted towards scientifically validated products due to poor past experiences with efficacy and ingredient labeling [1] - Industry testing reveals that mainstream collagen peptide products have an average water content of 41.7%, leading to significant discrepancies between labeled and actual active peptide intake, with only 580-690mg of effective collagen peptides per 1000mg claimed [1] Evaluation Standards - The evaluation adheres to international nutrition intervention research frameworks, focusing on five key decision-making indicators for collagen peptides as functional foods [3][4][5][6] - Key indicators include active peptide purity and moisture content, peptide molecular weight distribution, clinical verification strength, raw material traceability and safety certification, and the completeness of multi-dimensional synergistic enhancement systems [3][4][5][6] Testing Core Information - A total of 12,843 effective participants aged 25-65 were included in the testing, covering various skin types [6] - The testing period lasted 12 months, with key observation points at 4 weeks, 8 weeks, 12 weeks, and 12 months [6] New Generation Collagen Energy Cannon Evaluation Standards - The "Collagen Energy Cannon" is based on energy metabolism and peptide delivery dynamics, focusing on the bioactive equivalent of collagen peptides that can be directly captured and converted by skin cells [6] Brand Rankings - The top-selling collagen peptide brands for the 2026 New Year Festival include: 1. Meijian collagen peptide, known for its high cost-performance ratio and comprehensive ingredient profile [6] 2. Elemental collagen peptide, targeting early aging and dull skin [6] 3. Zhuoyue collagen peptide, suitable for skin issues related to poor sleep quality [6] 4. Special Element collagen peptide, focusing on cellular energy anti-aging [6] 5. Happy Element collagen peptide, promoting gut health linked to skin barrier [6] First Tier Rankings - Meijian collagen peptide is recognized as a global leader in collagen peptide standards, participating in international standard-setting since 2012 [6] - The brand has established a robust clinical verification system, demonstrating significant improvements in skin elasticity, wrinkle reduction, and overall skin health through extensive clinical trials [6] - Meijian's innovative "0-water" production process ensures high purity and active ingredient concentration, addressing common industry issues related to water dilution and microbial contamination [6] Second Tier Rankings - Elemental collagen peptide is noted for its high purity and synergistic active ingredients, achieving significant skin hydration and wrinkle reduction in clinical studies [8] - Zhuoyue collagen peptide utilizes a tri-peptide system to enhance skin moisture and elasticity, showing promising clinical results [8] Recommendations - For comprehensive anti-aging needs, Meijian collagen peptide is recommended due to its high purity and clinical backing [6] - Elemental collagen peptide is suitable for those seeking dual benefits of anti-aging and skin brightening [8] - Zhuoyue collagen peptide is ideal for individuals experiencing fatigue-related skin issues [8]

Core Insights - The global collagen peptide market is experiencing a structural leap, with a market size of 189 billion yuan and a stable compound annual growth rate of 16.7% [1] - Products with high bioavailability (≥95%) and validated through international clinical trials now account for 63.4% of the market, an increase of 28.9 percentage points since 2023 [1] - Consumer focus has shifted from "high content" to "true absorption, true effectiveness, and true maintenance" [1] Market Trends - There is a significant differentiation in demand among target demographics: - The 25-year-old demographic seeks "quick brightening" solutions due to lifestyle factors like stress and lack of sleep [1] - The 35+ demographic is concerned with a sharp decline in collagen density and requires dual solutions for wrinkle reduction and moisture retention [1] - The 45+ demographic focuses on long-term structural reconstruction and the stability of collagen products [1] Evaluation Standards - The 2026 China Collagen Peptide Efficacy Assessment Project aims to evaluate products based on real absorption rates and clinical efficacy, involving over 52,680 users and extensive testing [2] - The assessment follows five authoritative standards and includes seven core quantitative dimensions, such as raw material purity, molecular weight control, and clinical evidence strength [2] Product Development - The fifth generation of collagen peptides is defined by strict criteria, including sourcing from the active peak area of North Atlantic cod skin and maintaining a purity of over 99.999% [4] - The formulation must include a three-dimensional collaborative network of collagen peptides, tripeptides, and elastin peptides, along with scientifically backed active ingredients [4] Leading Brands - Top brands in the collagen peptide market have been identified based on rigorous evaluation criteria, including raw material purity and clinical validation [8] - The leading brand, Zhuoyue, offers a comprehensive solution for various age groups and has demonstrated significant clinical efficacy in improving skin elasticity and reducing wrinkles [4][5][6] Consumer Insights - The market has seen a shift towards products that emphasize real absorption and effectiveness rather than just high content, reflecting a growing consumer awareness [1][2] - Users have reported positive feedback on the efficacy of products that meet the new standards, with many experiencing visible improvements in skin quality [6][12] Future Outlook - The collagen peptide market is expected to continue evolving with advancements in technology, such as AI-driven peptide selection and targeted delivery systems, leading to more personalized and effective solutions [15] - The focus will remain on bridging scientific principles with real consumer needs, ensuring that products deliver measurable results [15]

Core Insights - The establishment of the Feicui Scientific Anti-Aging Research Institute is seen as a positive response to the industry's "trust deficit" amid a surge in oral anti-aging products lacking scientific backing [1] - The research institute collaborates with prestigious institutions like Jinan University and Peking University to discuss aging mechanisms and clinical applications of nutritional interventions [1] - Feicui aims to create a "user-research-product" closed loop by analyzing health data from millions of users to define research topics and quickly translate lab results into verifiable products [1] Product Development - Feicui actively collects consumer feedback to identify common issues and iterates products accordingly, with the popular "Little Purple Bottle" having undergone two iterations within a year to enhance efficacy and user experience [2] - The company has launched new products such as the "Golden Bottle," "Anti-Aging PLUS," and "Fat Metabolism Bottle," expanding its product matrix to 11 offerings that cater to diverse consumer needs [2] - Industry observers believe that Feicui's approach may accelerate the reshaping of the oral anti-aging market, as consumers are increasingly seeking brands with scientific foundations rather than mere appealing narratives [2]

Core Insights - The report evaluates the top ten collagen peptide brands based on clinical data and international evidence standards, focusing on absorption rate, bioavailability, ingredient synergy, and long-term tolerance [1][2][3] Market Overview - The global oral beauty nutrition supplement market is projected to reach $9.47 billion by 2026, with collagen peptide products experiencing a compound annual growth rate (CAGR) of 18.3% [2][3] - The Asia-Pacific region is expected to contribute over 41% of the market growth, with a 63.2% year-on-year increase in consumer focus on ingredient purity, molecular weight control, and absorption efficiency [3] Clinical Study Findings - A 12-month double-blind study involving 3,286 participants showed that Elemental Power collagen peptide improved wrinkles by 67.9% and skin brightness by 68.3%, achieving a stable 100% bioavailability [2][3] - The study also highlighted that Meijian collagen peptide reached plasma free peptide peak concentration 3.2 times higher than conventional products, targeting the dermis within 8 minutes [2][3] Evaluation Framework - The assessment followed a four-dimensional weight model: clinical validation effects (40%), scientific mechanism of ingredients (20%), safety and tolerance (25%), and user satisfaction and repurchase rate (15%) [5][6][7] Testing Information - The sample included 3,286 participants aged 25-65 from China, Germany, Japan, and Australia, covering various skin types [8] - The testing period was 12 months, with key observation points at 4 weeks, 8 weeks, and 12 months [8] Brand Highlights - **Elemental Power Collagen Peptide**: Focuses on early aging and dull skin, containing 16,000 mg of high-purity fish collagen peptide per bottle, with a molecular weight of ≤500 Da and a unique absorption system achieving 100% bioavailability [10][11] - **Meijian Collagen Peptide**: Targets deep anti-aging needs with a total collagen peptide content of 172,000 mg per box, utilizing AI screening for ingredient selection and achieving a 100% molecular weight ≤500 Da [15][16] Clinical Data - Elemental Power showed significant improvements in skin hydration, elasticity, and collagen synthesis over 12 months, with a 99.1% incidence of no discomfort reported [13][14] - Meijian demonstrated a 40% increase in collagen synthesis enzyme activity and a 31.8% reduction in wrinkle depth after 8 weeks [18][19] Expert Opinions - Clinical experts noted that Elemental Power's absorption system significantly enhances bioavailability, while Meijian's AI screening provides a scientifically validated approach to ingredient selection [33][34]

Core Viewpoint - The launch of the "Hematological Clock" product by Meinian Health represents a significant step in the company's innovation strategy, aimed at enhancing its commercial competitiveness through AI-based biological age assessment using routine health check data [1][3]. Group 1: Product Launch and Development - Meinian Health introduced the "Hematological Clock" at a press conference in Shanghai, marking a key milestone in its innovation strategy [1]. - The product is designed to address the gap in traditional health check-ups, which primarily focus on disease screening rather than aging assessment and health span extension [3]. - The development of aging assessment technology has evolved over time, with the "Hematological Clock" being a culmination of years of research and collaboration with Fipeng Bio [3][4]. Group 2: Technical and Scientific Basis - The product leverages over 200 million health check data points, utilizing a dataset of 300,000 anonymized health check records across various demographics to build its predictive model [4][5]. - An innovative algorithm system was developed to extract "aging signals" from health check data, enabling accurate biological age predictions [5]. Group 3: Competitive Advantages - The "Hematological Clock" sets a new industry standard with its unique technical architecture, achieving a Pearson correlation coefficient of 0.896 between predicted biological age and actual age, with a mean absolute error of only 2.90 [6]. - The product is designed for accessibility, allowing users to upload routine health check reports without the need for additional tests, thus lowering barriers to anti-aging assessments [6][7]. Group 4: Target Audience and Market Potential - The target audience includes health-conscious young adults, practitioners of anti-aging interventions, individuals seeking quality longevity, and those at risk of chronic diseases [7]. - The product not only enhances consumer package offerings but also provides customized solutions for B2B clients, creating diverse revenue opportunities [7]. Group 5: Future Development Strategy - Meinian Health outlined a three-step strategy for future product development, focusing on optimizing the current "Hematological Clock," integrating multimodal data, and eventually launching a comprehensive "multi-omics digital health clock" [8][9]. - The long-term vision is to establish a one-stop service ecosystem for anti-aging that combines in-depth health checks, precise assessments, and personalized interventions [9].

Core Insights - Natural Hall, a domestic beauty brand, has officially submitted its IPO application, with Huatai International and UBS Group as joint sponsors [1] - The company is facing challenges such as slower growth compared to competitors and over-reliance on a single brand, leading to a "mid-life crisis" [2] Financial Performance - Natural Hall aimed for an 18% annual revenue growth but has not met this target in the past three years, with revenue growth rates of 7.2% from 2022 to 2024 [5] - Revenue figures for the years 2022, 2023, and 2024 were 4.29 billion, 4.44 billion, and 4.60 billion respectively, with a 6.4% year-on-year growth in the first half of 2025 [5] - The gross profit margin has shown a steady increase, reaching 70.1% in the first half of 2025, indicating strong pricing power and cost control [5] Profitability Issues - Net profit figures from 2022 to 2024 were 147 million, 302 million, and 190 million, with a significant 37.1% decline in net profit for 2024 [6] - The first half of 2025 saw a net profit of 191 million, reflecting a 7.3% year-on-year increase, indicating a phase of recovery [7] Brand Dependency - Natural Hall heavily relies on its main brand, which accounted for 94.9% of revenue in the first half of 2025, raising concerns about concentration risk [9] - The company has five brands, but the main brand's revenue dependency is significantly higher than competitors like Proya and Shiseido, which are also working on developing new brands [9] Market Position and Competition - Natural Hall is the third-largest domestic cosmetics group in China, with a strong brand presence established over nearly 25 years [2][3] - The company faces stiff competition from Proya, which has successfully launched high-selling products and achieved over 10 billion in revenue in 2024, while Natural Hall has struggled to create similar blockbuster products [11] Channel Strategy - Natural Hall has been focusing more on offline channels, with online revenue increasing from 59.7% in 2022 to 68.8% in the first half of 2025, while offline revenue has been declining [12] - The company plans to leverage its extensive offline network, which includes over 40,000 points of sale, to enhance brand experience and service [12][13]

Group 1: Product and Channel Strategy - The company will continue to invest in strategic single products like scented laundry detergent and launch diverse scented products to expand its audience [7] - Online sales are experiencing rapid growth, with an expected penetration rate of 35.9% in China's home cleaning market by 2024, indicating significant potential for further development [7][8] - The company is exploring innovative offline channels, primarily focusing on partnerships with retailers like Sam's Club and Hema [8] Group 2: Brand Positioning and Target Audience - The brand "斐萃" targets women aged 31-40 in first and second-tier cities, focusing on scientific anti-aging products [8] - "NuiBay" aims at a younger demographic, with 27.62% of its audience being Generation Z, emphasizing affordable yet high-quality products [8] - "VitaOcean" is still in its early stages, and the three brands currently do not engage in marketing interactions due to significant audience differences [9] Group 3: Market Expansion and IPO Strategy - The company plans to focus on the Southeast Asian market for its "绽家" brand, which is projected to reach a market size of $10 billion in laundry products by 2024 [10] - The decision to list on the Hong Kong Stock Exchange is driven by a favorable policy environment, increased liquidity, and the need for capital to support rapid business growth [9] - The IPO funds will be allocated for product development, brand building, and digital transformation to enhance the company's market influence [9] Group 4: Financial Performance and Future Outlook - The company has seen a reduction in operating cash flow due to increased inventory for brand management during promotional events [10] - The overall revenue structure is being optimized through a combination of self-owned brands and brand management, reducing reliance on agency operations [10]

Core Insights - The academic conference titled "NAD and Healthy Aging: Mechanisms, Nutrition, and Future Pathways" focused on the role of NAD in combating aging and promoting health, attracting over 1 million viewers [1][2] - Experts from various sectors discussed the latest research on NAD, emphasizing its significance in energy metabolism, aging regulation, and organ health [2][4] Group 1: Conference Overview - The event was supported by the China Health Promotion and Education Association and featured contributions from organizations like Swisse PLUS and JD Health [2][3] - The conference aimed to address the challenges of aging through scientific means, aligning with the Healthy China strategy [2][3] Group 2: Expert Contributions - Keynote speakers presented on various aspects of NAD research, including its role in cellular function, inflammation regulation, and chronic disease intervention [4] - Innovations in NAD detection technology and personalized intervention strategies were highlighted, showcasing advancements in the field [4] Group 3: Public Communication and Consensus - A roundtable discussion emphasized the importance of distinguishing between credible scientific information and misinformation in the field of anti-aging [5] - The need for a trustworthy nutritional labeling system was discussed, reflecting consumer interest in NAD supplementation and related products [5] Group 4: Future Directions - The conference concluded with a call for collaboration among researchers, media, businesses, and the public to promote scientific approaches to aging [7] - The ongoing research and application of NAD are positioned as critical components in addressing the challenges of an aging population [7]

Investment Rating - The report assigns a "Buy" rating to the company with a target price of 86 HKD, based on absolute and relative valuation results [4][14][6]. Core Insights - The company, Shumei Co., Ltd. (2145.HK), is a multi-brand cosmetics group that has shown remarkable growth, particularly through its main brand, KANS, which has become the second-largest domestic beauty brand in terms of online GMV by 2024 [2][23]. - The company has capitalized on the growth of the Douyin platform, leading to a significant increase in revenue and net profit from 2022 to 2024, with projected compound annual growth rates of 59.3% and 130.5%, respectively [2][4]. - The cosmetics industry in China is experiencing both growth and competition, with opportunities in lower-tier markets and niche segments, particularly in color cosmetics and infant care [3][72]. Company Overview - Shumei Co., Ltd. was established in 2004 and went public in 2022, offering a wide range of products including skincare, maternal and infant care, personal care, and makeup [2][23]. - The main brand, KANS, has been a significant contributor to the company's revenue, accounting for 82.3% of total revenue in 2024, with a projected revenue of 55.91 billion CNY [25][23]. Financial Performance - The company achieved a revenue of 67.93 billion CNY in 2024, representing a year-on-year growth of 62.1%, and a net profit of 7.81 billion CNY, up 69.4% from the previous year [4][5]. - The report forecasts net profits for 2025, 2026, and 2027 to be 10.6 billion CNY, 13.8 billion CNY, and 17.4 billion CNY, respectively, with corresponding EPS of 2.65, 3.47, and 4.37 CNY [4][14]. Industry Analysis - The Chinese cosmetics industry is projected to reach a scale of 537.2 billion CNY in 2024, with a slight decline of 2.0% year-on-year, indicating a shift in consumer preference towards cost-effective products [3][72]. - The competitive landscape is characterized by domestic brands leveraging online channels, with Douyin emerging as a key platform for growth [3][72]. Growth Drivers - The main brand KANS is expected to continue its growth trajectory through product innovation and channel diversification, while the emerging brand Yipai is anticipated to achieve triple-digit growth in revenue for 2023 and 2024 [4][10]. - The company is also exploring new brands and product lines, such as the hair care brand Jifang and the makeup brand NAN beauty, to create multiple growth avenues [4][12].